<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
<channel>
<title>Blogcritics: Comments on Abiomed</title>
<link>http://blogcritics.org/</link>
<description>A sinister cabal of superior bloggers on music, books, film, popular culture, politics, and technology - updated continuously.</description>
<language>en</language>
<copyright>Copyright 2005 by the authors</copyright>
<lastBuildDate>Thu, 27 Jan 2005 16:01:31 EST</lastBuildDate>
<docs>http://backend.userland.com/rss</docs>
<generator>Blogcritics.org custom software</generator>

<item>
<title>Comment by Aaman</title>
<link>http://blogcritics.org/archives/2005/01/27/132606.php#comment-112499</link>
<description>Robert, thank you for your comments. I myself am a long term investor, but prefer to play it safe by only investing in &quot;Foolish Four&quot; type stocks and Type 1 stocks. This does not fit the bill - yet. Like I mentioned, interesting product.</description>
<guid isPermaLink="false">112499@blogcritics.org</guid>
<pubDate>Thu, 27 Jan 2005 16:01:31 EST</pubDate>
</item>
<item>
<title>Comment by Robert T DeMarco</title>
<link>http://blogcritics.org/archives/2005/01/27/132606.php#comment-112496</link>
<description>Aaman, I would agree with your technical analysis at this point in time. However, the black out on the mechanical heart is due to their application for the humanitarian device exception. The company announced sometime ago they were suspending testing of this device concurrent with their application.

The AB5000 business is growing fast and they have only gotten to about one percent of the addressable market.

As I stated clearly at the top of the post. This was intended for information only and I own the stock. A good investor looking for ideas could decide to investigate the story and then buy or short the stock. So you or anyone else is free to do as they see fit.

I am not a stockbroker nor do I work for the company. I do have an investor blog.

My real intention was to bring this story into the awareness of investors looking for ideas. This stock is not widely covered by research analyst at this time because the float is small and the volume is small. The Company did present at a Piper Jaffrey conference yesterday.

Nevertheless, the company has intriguing technology and a world class management team.

On the technical front you could have made the same comment when the stock dropped from the $14.00 area to the $8.50 area and you would have been correct for a time. But the methodolgy you described is more suited for short term trading from my point of view.

I feel the story behind this story is fundamental. Because both markets are enormous. But, that is my opinion on this one.

Perhaps we can come back to this post in a few months and discuss the price and the developments in the company at that time.


Meanwhile, I am open to new ideas on emerging companies if you have some. You never know where the next good investing idea is going to come from or who is going to supply the idea.

I am sorry I offended Shark. Please feel free to ignore me. Nevertheless, its OK by me if you prefer to spit venom.

Bob
</description>
<guid isPermaLink="false">112496@blogcritics.org</guid>
<pubDate>Thu, 27 Jan 2005 15:58:31 EST</pubDate>
</item>
<item>
<title>Comment by bhw</title>
<link>http://blogcritics.org/archives/2005/01/27/132606.php#comment-112492</link>
<description>I&#039;ll check with Eric on this one....</description>
<guid isPermaLink="false">112492@blogcritics.org</guid>
<pubDate>Thu, 27 Jan 2005 15:51:54 EST</pubDate>
</item>
<item>
<title>Comment by Temple Stark</title>
<link>http://blogcritics.org/archives/2005/01/27/132606.php#comment-112486</link>
<description>This does read exaclt like spam I get.

Is this a paid spot? Because that&#039;s what Blogads are for.

</description>
<guid isPermaLink="false">112486@blogcritics.org</guid>
<pubDate>Thu, 27 Jan 2005 15:32:16 EST</pubDate>
</item>
<item>
<title>Comment by Aaman</title>
<link>http://blogcritics.org/archives/2005/01/27/132606.php#comment-112478</link>
<description>Let&#039;s beat him at his own game: some numbers about this company:

EPS: -0.26 

Moving Average Convergence/Divergence (MACD) indicates a Bearish Trend.
Chart pattern indicates a Strong Downward Trend.
Relative Strength is Bearish.
Up/Down volume pattern indicates that the stock is under Distribution.
The 50 day Moving Average is falling which is Bearish.
Zacks Rank for ABIOMED INC (ABMD):
[ 4 ] SELL Stocks with a Zacks Rank of 4 are considered a SELL and are the second lowest rating given by Zacks.

&lt;a href=&quot;http://tinypic.com/1gstnr&quot;&gt;Here is a graph&lt;/a&gt; of the stock, showing the insider sales through the last year - note the pattern and lack of insider purchases.

&lt;a href=&quot;www.onthemedia.org/transcripts/ transcripts_072801_abiomed.html&quot;&gt;Here is an interesting article&lt;/a&gt; about their attempts on avoiding publicity - a news blackout on their heart device</description>
<guid isPermaLink="false">112478@blogcritics.org</guid>
<pubDate>Thu, 27 Jan 2005 15:16:25 EST</pubDate>
</item>
<item>
<title>Comment by Shark</title>
<link>http://blogcritics.org/archives/2005/01/27/132606.php#comment-112467</link>
<description>This guy has polluted the site before. He uses it for MARKETING. It&#039;s cheap.

Go away, motherfucker.</description>
<guid isPermaLink="false">112467@blogcritics.org</guid>
<pubDate>Thu, 27 Jan 2005 14:43:18 EST</pubDate>
</item>
<item>
<title>Comment by Aaman</title>
<link>http://blogcritics.org/archives/2005/01/27/132606.php#comment-112455</link>
<description>This is an advert - not really a blogpost. Interesting product, though.</description>
<guid isPermaLink="false">112455@blogcritics.org</guid>
<pubDate>Thu, 27 Jan 2005 14:20:05 EST</pubDate>
</item>

</channel>
</rss>